Dengue - Sample Collection Study Pakistan
ConditionDengue
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorAbbott Rapid Dx
About this trial
The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.
Eligibility criteria
Qualifiers
Age ≥12-years-old
Individuals suspected or confirmed for active dengue, with dengue-consistent symptoms onset up to and including 10 days before enrolment in this trial.
Disqualifiers
Subject has been vaccinated for dengue.
Subject participates in an investigative drug, vaccine or medical device clinical study
Participant is deemed unfit for the study by the Investigator
Participant is unwilling or unable to provide informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 2 trial groupsLocations
Sponsors and collaborators
Abbott Rapid Dx
Lead sponsor
Aga Khan University
Collaborator
National University of Medical Sciences, Pakistan
Collaborator
Source ClinicalTrials.gov